Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...

While Netflix and Meta stock shake off market volatility, Eli Lilly and this biotech stock join them and others on IBD ...

Shares in Palantir Technologies (PLTR) surged higher today after a leading analyst said it was poised to benefit from President Trump’s ...

It rose 341% in just a year, and 2025 hasn't been so bad, either. It has risen around 20% so far this year, but at the time ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

Wall Street stocks largely climbed in early trading Monday, as the United States faces down a tariff deadline with fresh ...

Palantir is exhibiting strength as investors react to Wall Street's latest endorsement of the company's role as a key dfense ...

We recently published an article titled Jim Cramer Discusses These 12 Stocks & Says Late Selloffs Are Deliberate. In this ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

A market rally attempt is underway after big losses. Here's what to do. Trump comments sent Bitcoin and other ...

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Palantir Technologies (PLTR – Research Report), with a price ...